Skip Navigation

European Heart Journal 1989 10(Supplement F):15-21; doi:10.1093/eurheartj/10.suppl_F.15
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Burnstock, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burnstock, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Vascular control by purines with emphasis on the coronary system

G. Burnstock

Department of Anatomy and Developmental Biology, and Centre for Neuroscience, University College London U.K.

Address for correspondence: G. Burnstock, Department of Anatomy and Developmental Biology, University College London, Gower St, London WC1E 6BT, U.K.

There is growing evidence for several different roles for purines in the control of blood flow. (1) Adenosine 5'-triphosphate (ATP) acts as a cotransmitter with noradrenaline and neuropeptide Y released from sympathetic perivascular nerves. In most vessels it acts via P2x-purinoceptors to produce vasoconstriction synergistically with {alpha}-adrenoceptor activation, while in some coronary vessels it appears to act via P2y-purinoceptors to produce vasodilatation in concert with β-adrenoceptor activation. (2) Adenosine, via P1-purinoceptors, acts as a prejunctional modulator of transmitter release from perivascular nerves; it also acts directly on vascular smooth muscle to produce vasodilatation. (3) ATP is stored in and released from vascular endothelial cells (including those from the coronary bed) during changes in blood flow or during hypoxia, and acts via P2Y-purinoceptors on endothelial cells to release endothelium-derived relaxing factor, resulting in vasodilatation. (4) ATP may be released together with substance P and calcitonin gene-related peptide from some sensory nerves during ‘axon-reflex’ activity when antidromic impulses pass down collaterals supplying blood vessels. (5) Finally, there is evidence to suggest that ATP released from intrinsic (non-sympathetic) neurones in the airways and heart has potent actions on the resistance vessels.

Key Words: Purinergic • peptidergic • neuromodulation • cotransmission • EDRF • purinoceptors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Physiol.Home page
A. M Coney and J. M Marshall
Contribution of adenosine to the depression of sympathetically evoked vasoconstriction induced by systemic hypoxia in the rat
J. Physiol., June 1, 2003; 549(2): 613 - 623.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Malmsjo, A. Bergdahl, X.-H. Zhao, X.-Y. Sun, T. Hedner, L. Edvinsson, and D. Erlinge
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure
Cardiovasc Res, July 1, 1999; 43(1): 200 - 209.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.